|
|
TCRT-PGEN Fundamental & Technical Discussion Board
|
|
||
Re: GILD/KITE TRIAL--- How many patients do they have enrolled by the NCI? Timeline and the Buyout Not sure if I have this right. 2016 Jan 07-- 2016 Announcement Kite Pharma Expands Its Clinical and Research Partnership With the National Cancer Institute (NCI) for Next-Generation CAR Programs to Treat B-Cell MalignanciesKite share price on 1/11/2016 $55.63 1 year- 1 month Kite share price on 2/27/2017 $72.53---Spark in volume 5.26Million shares start of uptrend in the stock: 2017 August 02---2017 First patient Kite Doses First Patient in the Phase 2 Trial of Axicabtagene Ciloleucel in Indolent B-Cell Non-Hodgkin Lymphoma (ZUMA-5)Kite share price on 08/07/2017 $120.00 2017--Aug 28 -- Gilead Sciences buys Kite Gilead Sciences to Buy Kite Pharma for $11.9 Billion: Is It Enough to Move the Needle?https://www.fool.com/investing/2017/08/28/gilead-sciences-to-buy-kite-pharma-for-119-billion.aspx Kite share price on 08/07/2017 $178.00 |
return to message board, top of board |